Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20121
20143
20151
20161
20174
20181
20201
20213
20221
20234
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Active, not recruiting4
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
European Organisation for Research and Treatment of Cancer - EORTC2
Advanced Accelerator Applications1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Celgene1
Clovis Oncology, Inc.1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma24
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms4
Anus Neoplasms1
Breast Neoplasms1
Carcinoma, Small Cell1
Colorectal Neoplasms1
Hereditary Sensory and Autonomic Neuropathies1
Melanoma1
Neoplasms1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.